FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W3157310985> ?p ?o ?g. }

• W3157310985 endingPage "adv00462" @default.
• W3157310985 startingPage "adv00462" @default.
• W3157310985 abstract "The efficacy of psoriasis treatments is usually evaluated using the Psoriasis Area and Severity Index (PASI). However, there is a lack of systematic statistical assessments of PASI as a proxy for systemic disease in individual patients. Therefore, a retrospective study of 186 treat-ments with adalimumab, etanercept, and ustekinumab for psoriasis (341 patient-years) was performed. While PASI significantly and independently correlated with biomarkers of systemic inflammation (especially neutrophil-to-lymphocyte ratio, C-reactive protein), the strengths were only weak-to-moderate and varied considerably inter-individually. A decrease in PASI indicated a neutrophil-to-lymphocyte ratio decrease and a C-reactive protein decrease or stable low margin C-reactive protein in ≥ 80%. Sensitivity, specificity, and positive predictive value of PASI 0 and PASI 2.75 (optimal Youden Index) for low cardiovascular risk C-reactive protein were 24%, 92%, 85%, and 62%, 61%, 76%, respectively. Performance was similar using absolute thresholds and PASI 100 or PASI 75, and overall worse for low cardiovascular risk neutrophil-to-lympho-cyte ratio and if psoriasis arthritis was present. In conclusion, PASI allows robust low-order estimates of systemic inflammation, but cannot substitute for laboratory biomarkers for more precise assessments." @default.
• W3157310985 created "2021-05-10" @default.
• W3157310985 creator A5002731519 @default.
• W3157310985 creator A5004350096 @default.
• W3157310985 creator A5011815489 @default.
• W3157310985 creator A5017523407 @default.
• W3157310985 creator A5082049025 @default.
• W3157310985 date "2021-01-01" @default.
• W3157310985 modified "2023-09-23" @default.
• W3157310985 title "Evaluation of Psoriasis Area and Severity Index as a Proxy for Bio­markers of Systemic Disease under Treatment with Tumour Necrosis Factor-alpha and Interleukin 12/23 Antagonists in Patients with Psoriasis: A Retrospective Cohort Study of 186 Treatment Cycles" @default.
• W3157310985 cites W1515251814 @default.
• W3157310985 cites W1828616852 @default.
• W3157310985 cites W1976897149 @default.
• W3157310985 cites W1978855446 @default.
• W3157310985 cites W1983469765 @default.
• W3157310985 cites W2003982930 @default.
• W3157310985 cites W2010257613 @default.
• W3157310985 cites W2031045752 @default.
• W3157310985 cites W2064618066 @default.
• W3157310985 cites W2082803782 @default.
• W3157310985 cites W2087484885 @default.
• W3157310985 cites W2108842111 @default.
• W3157310985 cites W2128722360 @default.
• W3157310985 cites W2143003624 @default.
• W3157310985 cites W2158489950 @default.
• W3157310985 cites W2590477100 @default.
• W3157310985 cites W2592535678 @default.
• W3157310985 cites W2613229008 @default.
• W3157310985 cites W2613530859 @default.
• W3157310985 cites W2614065762 @default.
• W3157310985 cites W2617191705 @default.
• W3157310985 cites W2756408557 @default.
• W3157310985 cites W2789988397 @default.
• W3157310985 cites W2795583931 @default.
• W3157310985 cites W2796008823 @default.
• W3157310985 cites W2799473857 @default.
• W3157310985 cites W2804753859 @default.
• W3157310985 cites W2902033804 @default.
• W3157310985 cites W2902932442 @default.
• W3157310985 cites W2921012991 @default.
• W3157310985 cites W2949717647 @default.
• W3157310985 cites W2963660305 @default.
• W3157310985 cites W3016471994 @default.
• W3157310985 cites W4210347219 @default.
• W3157310985 cites W4211077900 @default.
• W3157310985 doi "https://doi.org/10.2340/00015555-3814" @default.
• W3157310985 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/33903917" @default.
• W3157310985 hasPublicationYear "2021" @default.
• W3157310985 type Work @default.
• W3157310985 sameAs 3157310985 @default.
• W3157310985 citedByCount "0" @default.
• W3157310985 crossrefType "journal-article" @default.
• W3157310985 hasAuthorship W3157310985A5002731519 @default.
• W3157310985 hasAuthorship W3157310985A5004350096 @default.
• W3157310985 hasAuthorship W3157310985A5011815489 @default.
• W3157310985 hasAuthorship W3157310985A5017523407 @default.
• W3157310985 hasAuthorship W3157310985A5082049025 @default.
• W3157310985 hasBestOaLocation W31573109851 @default.
• W3157310985 hasConcept C126322002 @default.
• W3157310985 hasConcept C17991360 @default.
• W3157310985 hasConcept C203014093 @default.
• W3157310985 hasConcept C2776252253 @default.
• W3157310985 hasConcept C2776260265 @default.
• W3157310985 hasConcept C2776694085 @default.
• W3157310985 hasConcept C2776914184 @default.
• W3157310985 hasConcept C2777011040 @default.
• W3157310985 hasConcept C2777063308 @default.
• W3157310985 hasConcept C2777226972 @default.
• W3157310985 hasConcept C2778975655 @default.
• W3157310985 hasConcept C2779134260 @default.
• W3157310985 hasConcept C2780132546 @default.
• W3157310985 hasConcept C2780564577 @default.
• W3157310985 hasConcept C2781195455 @default.
• W3157310985 hasConcept C30036603 @default.
• W3157310985 hasConcept C47348012 @default.
• W3157310985 hasConcept C71924100 @default.
• W3157310985 hasConcept C74133956 @default.
• W3157310985 hasConcept C90924648 @default.
• W3157310985 hasConceptScore W3157310985C126322002 @default.
• W3157310985 hasConceptScore W3157310985C17991360 @default.
• W3157310985 hasConceptScore W3157310985C203014093 @default.
• W3157310985 hasConceptScore W3157310985C2776252253 @default.
• W3157310985 hasConceptScore W3157310985C2776260265 @default.
• W3157310985 hasConceptScore W3157310985C2776694085 @default.
• W3157310985 hasConceptScore W3157310985C2776914184 @default.
• W3157310985 hasConceptScore W3157310985C2777011040 @default.
• W3157310985 hasConceptScore W3157310985C2777063308 @default.
• W3157310985 hasConceptScore W3157310985C2777226972 @default.
• W3157310985 hasConceptScore W3157310985C2778975655 @default.
• W3157310985 hasConceptScore W3157310985C2779134260 @default.
• W3157310985 hasConceptScore W3157310985C2780132546 @default.
• W3157310985 hasConceptScore W3157310985C2780564577 @default.
• W3157310985 hasConceptScore W3157310985C2781195455 @default.
• W3157310985 hasConceptScore W3157310985C30036603 @default.
• W3157310985 hasConceptScore W3157310985C47348012 @default.
• W3157310985 hasConceptScore W3157310985C71924100 @default.
• W3157310985 hasConceptScore W3157310985C74133956 @default.
• W3157310985 hasConceptScore W3157310985C90924648 @default.

• next